Related Experiment Videos
Viral hepatitis: a sexually transmitted disease?
1Primary Care Center, Children's Hospital of Philadelphia, PA 19104, USA.
Insights
Hepatitis B and C are sexually transmitted diseases often overlooked in STD prevention. Vaccination prevents Hepatitis B, but Hepatitis C lacks a vaccine, leading to chronic liver disease in most infected individuals.
Area of Science:
- Hepatology
- Infectious Diseases
- Public Health
Background:
- Sexually transmitted diseases (STDs) discussions commonly exclude viral hepatitis.
- Hepatitis B virus (HBV) and Hepatitis C virus (HCV) are significant STDs with global health implications.
- HBV and HCV infections pose risks for chronic liver disease and cancer.
Purpose of the Study:
- To highlight the omission of viral hepatitis from STD prevention dialogues.
- To emphasize the public health importance of HBV and HCV as STDs.
- To advocate for the inclusion of HBV and HCV in STD prevention strategies.
Main Methods:
- Literature review on STD prevalence and viral hepatitis transmission.
- Analysis of incidence data for HBV and HCV in North America.
- Comparison of prevention methods, including vaccination for HBV and lack thereof for HCV.
Main Results:
- HBV is a vaccine-preventable STD with high incidence in North American young adults (15-25).
- HCV is a newly identified STD with no available vaccine, leading to chronic infection in the majority of cases.
- Both HBV and HCV are associated with increased risks of chronic liver disease and hepatocellular carcinoma.
Conclusions:
- Viral hepatitis, specifically HBV and HCV, must be integrated into STD prevention and counseling.
- Public health initiatives should address the sexual transmission of HBV and HCV.
- The lack of an HCV vaccine necessitates focused prevention efforts to mitigate chronic liver disease.
Abstract:
Sexually transmitted diseases (STDs) are often discussed in the context of herpes, gonorrhea, chlamydia, and AIDS. Viral hepatitis, specifically hepatitis B, is also an STD often omitted from these discussions. The incidence of hepatitis B virus (HBV) is variable throughout the world. In North America, the highest incidence occurs in patients who are between the ages of 15 and 25 years. Safe and effective vaccines are available to prevent HBV infection, which has an associated increased risk of chronic liver disease and hepatocellular carcinoma in the carrier state. Hepatitis C virus (HCV) is a newly identified hepatotrophic virus that may also be sexually transmitted. There are no vaccines for the prevention of HCV infection and the majority of those who are infected become chronic carriers with chronic liver disease. Discussions focused on the prevention of STDs must include counseling for the prevention of HBV and HCV.